- Home
- MVIS vs VNDA Comparison
MVIS vs VNDA Comparison
Compare MVIS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVIS
- VNDA
- Stock Information
- Founded
- MVIS 1993
- VNDA 2002
- Country
- MVIS United States
- VNDA United States
- Employees
- MVIS N/A
- VNDA N/A
- Industry
- MVIS Industrial Machinery/Components
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- MVIS Technology
- VNDA Health Care
- Exchange
- MVIS Nasdaq
- VNDA Nasdaq
- Market Cap
- MVIS 234.3M
- VNDA 270.0M
- IPO Year
- MVIS 1996
- VNDA 2006
- Fundamental
- Price
- MVIS $1.44
- VNDA $4.36
- Analyst Decision
- MVIS Buy
- VNDA Strong Buy
- Analyst Count
- MVIS 3
- VNDA 2
- Target Price
- MVIS $2.15
- VNDA $15.50
- AVG Volume (30 Days)
- MVIS 9.9M
- VNDA 522.7K
- Earning Date
- MVIS 02-26-2025
- VNDA 02-05-2025
- Dividend Yield
- MVIS N/A
- VNDA N/A
- EPS Growth
- MVIS N/A
- VNDA N/A
- EPS
- MVIS N/A
- VNDA N/A
- Revenue
- MVIS $8,147,000.00
- VNDA $190,858,000.00
- Revenue This Year
- MVIS $24.78
- VNDA $5.60
- Revenue Next Year
- MVIS $451.78
- VNDA $42.85
- P/E Ratio
- MVIS N/A
- VNDA N/A
- Revenue Growth
- MVIS 277.53
- VNDA N/A
- 52 Week Low
- MVIS $0.80
- VNDA $3.46
- 52 Week High
- MVIS $2.70
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- MVIS 59.99
- VNDA 34.28
- Support Level
- MVIS $1.22
- VNDA $4.77
- Resistance Level
- MVIS $1.36
- VNDA $4.95
- Average True Range (ATR)
- MVIS 0.20
- VNDA 0.15
- MACD
- MVIS -0.01
- VNDA -0.04
- Stochastic Oscillator
- MVIS 54.10
- VNDA 9.09
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.